Generic placeholder image

Current Cardiology Reviews


ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Long-term Results After Transcatheter Aortic Valve Implantation: What do we Know Today?

Author(s): Y. Elhmidi, S. Bleiziffer, N. Piazza, B. Voss, M. Krane, M-A. Deutsch and R. Lange

Volume 9 , Issue 4 , 2013

Page: [295 - 298] Pages: 4

DOI: 10.2174/1573403X09666131202124227

Price: $65


Transcatheter aortic valve implantation (TAVI) is evolving rapidly as a therapeutic option in patients deemed to be at high risk for surgical aortic valve replacement. Early outcome and survival of controlled feasibility trials and single- center experience with TAVI have been previously reported. Valve performance and hemodynamics seem to improve significantly after TAVI. Long-term outcome up to 3 years have been demonstrated in recent studies. Admittedly, the results are encouraging with a survival rate at 2 and 3 years ranging from 62 to 74% and from 56 to 61% respectively. The improvement in hemodynamical and clinical status sustained beyond the 3 years follows up. However, paravalvular leakage after TAVI remains an important issue in this rapidely evolving field.

Keywords: Aortic valve, TAVI, paravalvular leakage, aortic stenosis, SAVR.

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy